Skip to main navigation

Investors and Media

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jun 16, 2026
Document Date
Jun 12, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Kyntra Bio
Issuer
KYNTRA BIO, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Investors and Media

  • Investor Overview
  • Stock Information
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • SEC Filings
  • Financial Information
  • Shareholder Services
  • Investor FAQs

Kyntra Bio, Inc.

Volume:

Minimum 15 minutes delayed. Source: LSEG

Investor and Media Contact

  • Investors:
    David DeLucia, CFA
    Chief Financial Officer
    ir@kyntrabio.com

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • Terms of Use
  • Privacy Notice
  • About Us
  • Focus Area
  • Pipeline
  • Clinical Trials
  • Investors and Media
  • Terms of Use
  • Privacy Notice
  • © 2026 Kyntra Bio, Inc.
  • 350 Bay St, Ste 100 # 6009 San Francisco, CA 94133 USA